Paper26344622
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands.
Toussi DN and 1 other. Vaccines (Basel), 2014. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Papers, record 26344622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26344622
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI040944 | NIAID NIH HHS | United States | R01AI040944 | PubMed |
Source NIH RePORTER
References227
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14642305 | Porin of Shigella dysenteriae enhances mRNA levels for Toll-like receptor 2 and MyD88, up-regulates CD80 of murine macrophage, and induces the release of interleukin-12. | FEMS Immunol Med Microbiol | 2003 | https://conductscience.org/library/papers/14642305 | PubMed |
| 2 | 12527213 | Recognition of pathogen-associated molecular patterns by TLR family. | Immunol Lett | 2003 | https://conductscience.org/library/papers/12527213 | PubMed |
| 3 | 21624416 | Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. | Vaccine | 2011 | https://conductscience.org/library/papers/21624416 | PubMed |
| 4 | 5461121 | Inhibition of biologic activity of poly I: poly C by human plasma. | Proc Soc Exp Biol Med | 1970 | https://conductscience.org/library/papers/5461121 | PubMed |
| 5 | 16968658 | Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. | Vaccine | 2007 | https://conductscience.org/library/papers/16968658 | PubMed |
| 6 | 24291168 | Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/24291168 | PubMed |
| 7 | 15322147 | Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. | J Immunol | 2004 | https://conductscience.org/library/papers/15322147 | PubMed |
| 8 | 18304707 | Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge. | Vaccine | 2008 | https://conductscience.org/library/papers/18304707 | PubMed |
| 9 | 11160295 | Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. | J Immunol | 2001 | https://conductscience.org/library/papers/11160295 | PubMed |
| 10 | 15046255 | Advances in vaccine adjuvants for infectious diseases. | Curr HIV Res | 2003 | https://conductscience.org/library/papers/15046255 | PubMed |
| 11 | 17916463 | GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. | Vaccine | 2007 | https://conductscience.org/library/papers/17916463 | PubMed |
| 12 | 9734363 | MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. | Mol Cell | 1998 | https://conductscience.org/library/papers/9734363 | PubMed |
| 13 | 9607006 | Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. | Vaccine | 1998 | https://conductscience.org/library/papers/9607006 | PubMed |
| 14 | 23377752 | Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23377752 | PubMed |
| 15 | 11123327 | A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. | J Immunol | 2001 | https://conductscience.org/library/papers/11123327 | PubMed |
| 16 | 17890128 | Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. | Microbes Infect | 2007 | https://conductscience.org/library/papers/17890128 | PubMed |
| 17 | 2120344 | Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. | J Immunol | 1990 | https://conductscience.org/library/papers/2120344 | PubMed |
| 18 | 22106367 | Antigen depot is not required for alum adjuvanticity. | FASEB J | 2012 | https://conductscience.org/library/papers/22106367 | PubMed |
| 19 | 7814635 | Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7814635 | PubMed |
| 20 | 17558426 | The perfect mix: recent progress in adjuvant research. | Nat Rev Microbiol | 2007 | https://conductscience.org/library/papers/17558426 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582202 | Toll-like receptors in fish: evolution, structure, immune signaling, and translational prospects for adjuvant-based vaccine design in aquaculture. | Front Immunol | 2026 | https://conductscience.org/library/papers/42582202 | PubMed |
| 42483173 | Synthetic double-stranded RNA in antiviral immunity and vaccine adjuvant: insights into poly(I:C) and poly(A:U). | Front Immunol | 2026 | https://conductscience.org/library/papers/42483173 | PubMed |
| 42347631 | Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347631 | PubMed |
| 42216810 | Manganese Pyrophosphate Mineralized DNA Nanovaccine Elicits Potent Humoral and Cellular Immunity. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42216810 | PubMed |
| 42156388 | Redesign of TALE proteins for DNA-templated assembly of protein fibers. | Nat Commun | 2026 | https://conductscience.org/library/papers/42156388 | PubMed |
| 42146112 | Endogenous living adjuvants for cancer vaccination: Concepts, mechanisms, and design principles. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42146112 | PubMed |
| 41441649 | Optimizing Humoral Immunity for Durable and Broad Protection in Flavivirus Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41441649 | PubMed |
| 41019059 | The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways. | Front Immunol | 2025 | https://conductscience.org/library/papers/41019059 | PubMed |
| 41007341 | CP91110P: A Computationally Designed Multi-Epitope Vaccine Candidate for Tuberculosis via TLR-2/4 Synergistic Immunomodulation. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41007341 | PubMed |
| 40333326 | Destabilising Effect of Class B CpG Adjuvants on Different Proteins and Vaccine Candidates. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40333326 | PubMed |
| 40266223 | Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40266223 | PubMed |
| 40246950 | Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40246950 | PubMed |
| 40040700 | Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40040700 | PubMed |
| 39601191 | Progress and prospect of polysaccharides as adjuvants in vaccine development. | Virulence | 2024 | https://conductscience.org/library/papers/39601191 | PubMed |
| 38690283 | Designing of a multi-epitopes based vaccine against Haemophilius parainfluenzae and its validation through integrated computational approaches. | Front Immunol | 2024 | https://conductscience.org/library/papers/38690283 | PubMed |
| 38591323 | Vaccine adjuvants: current status, research and development, licensing, and future opportunities. | J Mater Chem B | 2024 | https://conductscience.org/library/papers/38591323 | PubMed |
| 38332005 | The scientific journey of a novel adjuvant (AS37) from bench to bedside. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/38332005 | PubMed |
| 38258035 | Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38258035 | PubMed |
| 37790926 | Surface immunogenic protein from Streptococcus agalactiae and Fissurella latimarginata hemocyanin are TLR4 ligands and activate MyD88- and TRIF dependent signaling pathways. | Front Immunol | 2023 | https://conductscience.org/library/papers/37790926 | PubMed |
| 37434263 | rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37434263 | PubMed |
Genes65
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26344622
GET https://conductscience.org/api/papers/v1/26344622/references?page=2